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Ngn3 (NEUROG3)ers of the CCN family of growth factors encoding extracellular matrix proteins
participating in several developmental and tumorigenic processes. Both are induced by the WNT signaling
pathway, and microarray data suggest that expression of WISP1 and CTGF is repressed by Neurogenin3 (Ngn3
(NEUROG3)), a transcription factor directing speciﬁcation of the endocrine pancreas. Single-cell reverse
transcription polymerase chain reaction analysis suggested that this was a cell autonomous effect. To identify
possible common regulatory networks involved in WISP1 and CTGF gene expression, their genomic regions
were searched for common transcription factor motifs using a combination of in silico approaches and
documented knowledge concerning pancreas development. This analysis revealed the presence of a
conserved enhancer in both CTGF and WISP1 regulatory regions in 10 species covering a wide evolutionary
distance. This enhancer contains binding sites for Ngn1/3 (NEUROG1/3) and transcription factors that are
critically involved in pancreas development. Furthermore, it contained binding sites for three additional
transcription factor families, which may indicate novel players are involved in this process.
© 2008 Elsevier Inc. All rights reserved.One of the foremost challenges of biological research is to decipher
the complex genetic regulatory networks responsible for embryonic
development.
The recent rapid accumulation of whole genome sequence data
and of genomewide transcriptional proﬁling methods, such as
microarrays, coupled with the development of sophisticated compu-
tational tools for exploiting and analyzing genomic data, provides a
signiﬁcant starting point for regulatory network analysis. The
linchpins of the regulatory networks are the cis-regulatory elements
that directly control gene expression through interpretation of the
transcriptional code, thus acting as sites of integration for the
combinatorial action of multiple signal transduction pathways and
tissue-speciﬁc selector proteins. The experimentally identiﬁed reg-
ulatory elements are usually also evolutionary conserved regions [1].
Transcription factor binding sites (TFBSs)1, being functionally impor-
tant regions, are thought to be better conserved, in comparison to the
remaining genomic sequences. Therefore, procedures such as phylo-
genetic footprinting should help us to identify conserved regulatory
elements by comparing genomic sequences among related species [1].site; CTGF, connective tissue
erse transcription polymerase
sulin-like growth factor; TSS,
as);
l rights reserved.The identiﬁcation of orthologous genes has been shown to play an
important role in the ﬁelds of comparative genomics, transcription
regulation, and genome annotation [2–4]. Orthologous genes have
diverged from a common ancestor and they usually share a high
percentage of sequence similarity and, likely, similar function [5].
Several genes involved in cancer progression have been identiﬁed
as molecular players of embryonic development pathways as well [6].
WNT-Induced Secreted Protein 1 (WISP1, or ELM1) is a cysteine-rich
protein belonging to the connective tissue growth factors with growth
regulatory functions. WISP1 is involved in crucial developmental and
tumorigenic processes [7–9] and is regulated by β-catenin [10].
Although WISP-1 involvement in tumor progression has attracted a
lot of attention, its function in normal biological processes remains to
be clariﬁed.
Connective tissue growth factor (CTGF) belongs to the same (CCN)
gene family as WISP1, encoding secreted cysteine-rich multimodular
proteins [11–15]. CTGF is also a secreted, extracellular matrix-
associated protein that regulates diverse cellular functions in different
cell types. It modulates many cellular functions, including prolifera-
tion, migration, adhesion, and extracellular matrix production.
Furthermore, CTGF has particular importance in skeletal develop-
ment, and it is involved in many biological and pathological processes
[16]. CTGF expression is regulated by WNT3A, and is also β-catenin-
dependent [17].
CTGF and WISP1 were found to be co-regulated by Ngn3 in an
embryonic stem cell (ESC)-based approach to identify novel Ngn3
302 M. Kapasa et al. / Genomics 92 (2008) 301–308target genes [18]. In this approach, mouse ESCs genetically engineered
to allow inducible Ngn3 expression were directed initially toward
endoderm and subsequently toward pancreatic endoderm by sequen-
tial addition of extracellular signals [18]. Inductionof Ngn3 at this stage
leads to activation of its known downstream targets, demonstrating
that an optimal cellular context has been generated to screen for novel
Ngn3 targets using microarray gene expression proﬁling. The micro-
array results revealed an almost fourfold reduction in the expression of
both CTGF and WISP1 in response to Ngn3 expression [18].
The already known common regulation of WISP1 and CTGF genes
by the WNT signaling pathway [7–9, 17] and our own experimental
data indicating that both genes are regulated by Ngn3 set them as
putative participants in pancreas development processes. In particular,
bothWISP1 and CTGF appear to be downregulated after the induction
of Ngn3 in cells whose transcription expression pattern has been
examined through microarray gene expression proﬁling. These data
placedWISP1 and CTGF genes in the focal point of an extended in silico
analysis concerning their phylogenetic relationship and potential
common mechanisms involved in their regulation at the transcrip-
tional level.
Toward this end, the orthologs of WISP1 from all currently
available genomes were identiﬁed and compared with CTGF orthologs
covering the same evolutionary distance. This analysis depicted the
high degree of conservation betweenWISP1 and CTGF orthologs at the
protein level.
To identify common regulatory networks, the orthologous pro-
moter regions of WISP1 were searched for putative regulatory motifs,
and several widely conserved transcription factor binding models
were identiﬁed. To focus our analysis on regulatory networks involved
in pancreas development, we selected a single widely conserved
model consisting of binding sites for Ngn3 and other pancreas-related
transcription factors. Next, we extended the search for this selected
framework of common transcription factors to CTGF gene orthologs.
Strikingly, this comparative phylogenetic footprinting analysis
revealed the presence of a cluster of ﬁve binding sites for transcription
factors involved in pancreas development, conserved in all species
examined for both WISP1 and CTGF orthologs. Furthermore, this
cluster contained binding sites for the LEF1 transcription factor that
mediates β-catenin-dependent WNT signaling [19,20]. The identiﬁca-
tion of additional conserved binding sites for transcription factors not
implicated so far in pancreas development suggested that this
approach holds promising predictive value as well.
We propose that this approach can be used for the identiﬁcation of
other evolutionary conserved regulatory modules, either verifying
experimental data or predicting promising targets for further
experiments.
Results
Analysis of CTGF and WISP1 expression in response to Ngn3 induction
To conﬁrm that CTGF andWISP1 are downregulated in response to
Ngn3 we performed semiquantitative RT-PCR analysis using ESC-Fig. 1. RT-PCR analysis of WISP1 and CTGF expression levels relative to Ngn3 induction in th
from semiquantitative RT-PCR performed in a population of differentiated ESCs (A) as wellderived pancreas progenitors inwhich Ngn3 expression had (+dox) or
had not (−dox) been induced. The results conﬁrmed that both CTGF
and WISP1 are repressed on Ngn3 expression (Fig. 1A). To determine
whether there was a direct correlation of relative transcript
abundance on a single-cell level, we performed single-cell semiquan-
titative RT-PCR. Individual cells that were exposed (+dox) or not
exposed (−dox) to Ngn3 expression were picked, and expression of
either Ngn3 and CTGF or NGN3 andWISP1was determined. Of 12 cells
assayed for Ngn3 and CTGF expression, 6 were Ngn3high/CTGFlow and 6
were Ngn3low/CTGFhigh, whereas of 12cells assayed for Ngn3 and
WISP1 expression, 6 were Ngn3high/WISP1low, 5 were Ngn3low/
WISP1high, and one was Ngn3low/CTGFlow (Fig. 1B). Some cells picked
from the dox-treated population were Ngn3-negative, but this was in
agreement with previous ﬁndings [18]. Therewas a perfect correlation
of Ngn3 induction with strong repression of both CTGF and WISP1
expression on the single-cell level, suggesting the possibility that
these genes are direct targets of Ngn3.
In silico analysis of WISP1 and CTGF genes
Ortholog identiﬁcation and phylogenetic analysis
As a ﬁrst step of our in silico analysis, we identiﬁed the orthologs of
WISP1. Twenty-one WISP1 orthologous peptides of all currently
available genomes were identiﬁed (Supplementary Table S1). Peptides
not found in public databases were constructed through expressed
sequence tag (EST) identiﬁcation, reconstitution, and translation or
generated through homology modeling using Wise2 (http://www.ebi.
ac.uk/Wise2/). (Table S1). These are referred to as “in silico generated
peptides.” Peptides showing only partial sequence similarity are
referred to as “partial.” Ten CTGF orthologs covering the same
evolutionary distance were also identiﬁed (Table S1). To conﬁrm
these ﬁndings we performed synteny analysis for both WISP1 and
CTGF identiﬁed orthologs of 10 organisms covering the evolutionary
distance from ﬁsh to mammals. Genes ﬂanking WISP1 are fully
conserved, whereas genes ﬂanking CTGF were conserved in all
organismswith the exception of fugu andmedaka. Protein alignments
demonstrated the high degree of conservation at the protein level
among WISP1 orthologs, as well as among CTGF orthologs (Supple-
mentary Figs. S1 and S2). Common topology of the two unrooted
cladograms is compatible with a potentially common evolutionary
history of WISP1 and CTGF (Supplementary Figs. S3a and b).
Functional domain identiﬁcation
CTGF and WISP1 share four common modules, the functionality of
which has been experimentally addressed. Module 1 is an insulin-like
growth factor (IGF)-binding domain [21,22], module 2 is a von
Willebrand type C domain [23], module 3 is a thrombospondin-1
domain [24,25], and module 4 is a C-terminal domain containing a
putative cystine knot [26–28] (Fig 2A).
We examined the extent to which these domains are evolutionarily
conserved and derived a consensus sequence for each domain. Using the
PFAM website (http://www.sanger.ac.uk/cgi-bin/Pfam/getblast?
id=205J65wHW75cGZ96V1) and themouse protein sequences as queries,e presence of dox. Both WISP1 and CTGF are repressed on induction of Ngn3 as evident
as in single cells (B).
Fig. 2. (A) The fourWISP1 and CTGF conserved functional domains are shown.Domain 1 is an insulin-like growth factor-binding domain (IGFBP), domain 2 is a vonWillebrand type C domain
(VWC), domain 3 is a thrombospondin-1 domain (TSP1), and domain 4 is a C-terminal domain containing a putative cystine knot (Cys-Knot). WISP1 (top) and CTGF (bottom) consensus
sequencesderived fromall the orthologouspeptides are shownnext to the respective domainsof theprotein. The relative size of the amino acids is determinedby their conservationmeasured
in bits (scale0–4 in the graph bar). (B) The alignments between theconsensus sequences of theWISP1 andCTGF respective domains shown in (A) exhibit high similarity along their full length.
303M. Kapasa et al. / Genomics 92 (2008) 301–308we identiﬁed the conserved domains of WISP1 and CTGF (Fig 2A). To
derive WISP1 and CTGF consensus sequences for each domain, we
selected the respective orthologous protein sequences (Figs. S1 and S2)
and fed them into the Weblogo (http://weblogo.berkeley.edu/logo.cgi).
The identiﬁed consensus sequences revealed that all domainswere
very well conserved, with similarities ranging from 53.1% (domain I)
to 73.9% (domain III) and identities ranging from 38.1% (domain IV) to
58.0% (domain II). The conservation between the consensus sequences
of the four domains for WISP1 and CTGF is illustrated in Fig 2B. These
data suggest that WISP1 and CTGF share common functionalities
residing in domains I–IV. Taking into account these ﬁndings as well as
the experimental evidence for common regulation, we set out to
identify conserved regulatory elements.
Regulatory region analysis
The degree of functional domain conservation (Figs. 2A and B)
suggested that conserved regulatory genomic regions controlling the
common regulation of these two genes from Ngn3 may also exist. Toaddress this question, we extracted the regulatory regions from 10WISP1
and CTGF orthologous genes covering the wide phylogenetic distance
fromhuman toﬁsh (Table S1) to perform comparative genomic analysis of
these regulatory sequences. These regions extended from 4000 bp
upstream of the transcription starting site (TSS) to 400 bp downstream
of the TSS andwere submitted for prediction of TFBSs. The putative TFBSs
common to all selected orthologs of bothWISP1 and CTGFwere classiﬁed
to the transcription factor families indicated in Table 1. Each transcription
factor family is characterized by a probability of random identiﬁcation of
its binding motifs in the submitted sequences. This probability is
expressed with the “P value” shown next to each transcription factor
family. The chosen transcription factor families have P values below the
cutoff (0.002) rendering them statistically signiﬁcant.
To identify conserved regulatory elements we searched for clusters of
conserved TFBSs (models) in WISP1 and CTGF selected orthologs using
Frameworker at the Genomatix database (http://www. genomatix.de/).
Two criteria were used to select a model(s) for further analysis: degree of
conservation and existence of at least one Ngn3 TFBS and as many as
Table 1
The transcription factor binding site families found in all 10 WISP1 and CTGF
orthologous genomic regions with their respective P valuesa
TF family P value TF family P value
PAX8 3.112 e-6 SNAP 7.243 e-4
PAX3 4.725 e-6 PERO 8.358 e-4
COMP 1.036 E-5 SRFF 8.703 e-4
CHRF 1.329 e-5 NFKB 0.001
HMTB 2.631 e-5 ZFXH 0.001
CDXF 3.590 e-5 RORA 0.002
GFI1 3.590 e-5 AP1R 0.002
NEUR 3.590 e-5 NFAT 0.002
HAML 5.403 e-5 HOMF 0.002
CP2F 7.218 e-5 MZF1 0.002
PRDF 1.490 e-4 GREF 0.002
HNF6 1.982 e-4 EGRF 0.005
TALE 2.029 e-4 RUSH 0.007
CEBP 2.677 e-4 E2FF 0.008
HESF 2.801 e-4 STAT 0.008
PBXC 2.801 e-4 IRFF 0.011
HNF1 3.912 e-4 CAAT 0.011
IKRS 4.087 e-4 SP1F 0.012
PDX1 4.177 e-4 AP4R 0.015
MEF2 4.269 e-4 PARF 0.017
P53F 5.181 e-4 HEAT 0.017
LEFF 6.396 e-4 BRNF 0.018
a Families with P values higher than 0.02 are not listed.
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analysis contained Ngn1/3, BRNF family, and PDX1 TFBSs and was
conserved in the same evolutionary distance from ﬁsh to mammals for
bothWISP1 andCTGF (Figs. 3A andB). Furthermore, HNF1 andHNF6TFBSs
appeared in close proximity to the cluster of Ngn1/3, PDX1, and BRNF
TFBSs in some species (data not shown). HNF1 (HNF1A) and HNF6
(ONECUT1) are also involved in pancreas speciﬁcation [30–32]. This
prompted us to extend our search in both directions to a region of 500–
1000 bp in total length to identify other transcription factors common to
all WISP1 and CTGF orthologs. Strikingly, members of all the previously
mentioned transcription factor familieswere identiﬁedwithin this region.
More precisely, the transcription factors PDX1 and ISL1, belonging to the
PDX1 family; BRN2 (POU3F2), BRN3 (POU4F3), BRN4 (POU3F4), and BRN5
(POU6F1), members of the BRNF family in various combinations; Ngn1/3;
and HNF1 and HNF6 co-localized in these genomic sequences. The length
of the region, where the common set of transcription factors is located,
varied between245 and 1886 bp for different orthologs. Single-nucleotide
polymorphisms were identiﬁed in some of the conserved transcription
factor binding sites, but these changes did not affect transcription factor
binding ability (as deﬁned by the MatInspector algorithm).
LEF1 is a transcription factor that mediates the effects of the
canonical WNT signaling pathway. Both CTGF and WISP1 have been
shown to be regulated by the canonical WNT pathway [19,20]. The
presence of LEF-1 TFBSs in this putative enhancer region further
supports the notion that it represents a common and evolutionarily
conserved WISP1 and CTGF regulatory module.
The putative enhancer regions with their common TFBSs distrib-
uted are shown in Fig. 4 for all WISP1 and CTGF orthologs. In this
conserved enhancer, common to all CTGF and WISP1 orthologs,
binding sites for elements belonging to the TF families AP4R, HOXF,
and OCT1 were identiﬁed (P values shown in Table 1). This ﬁnding
suggests that members of these large TF families may be involved in
pancreas differentiation processes. It is worth noting that the length of
the enhancer, as well as the order and orientation of the TFBS within
the enhancer, is not fully conserved. However, the simultaneous
presence of these TFBSs, their evolutionary conservation from ﬁsh to
mammals, and the high degree of sequence similarity of protein
domains suggest that we have indeed identiﬁed a common CTGF and
WISP1 regulatory module. This approach combining strict in silico
methods with ﬂexible, intuitive biological thinking could be imple-
mented in other studies.Discussion
Recent advanceshavemadepossible the genomewide analysis of gene
regulation through the use of microarray gene expression proﬁling and
the identiﬁcation of putative regulatory elements using chromatin
immunoprecipitation assays combined with chip technology or deep
sequencing.However,we lag inways tomanage theﬂoodofdata collected
using these technologies. In anattempt to address this issue,we combined
computational approaches, experimental data from microarray gene
expression proﬁling, and documented knowledge concerning pancreas
development to identify putative regulatory elements in the genomic
region ofWISP1 and CTGF, twomembers of the CCN growth factor family.
Twenty-one WISP1 orthologs from genomes currently available in
public databases, as well as CTGF orthologs from species covering the
same phylogenetic distance, were identiﬁed. All four functional
domains were found to be highly conserved across species, and the
WISP1 and CTGF phylogenetic trees were compatible in topology.
The analysis of orthologous WISP1 and CTGF promoter regions in
combinationwith the experimental data fromour laboratory consolidated
the notion that WISP1 and CTGF are direct targets of Ngn3. Setting the
NGN1/3 binding site as a mandatory element in WISP1 and CTGF
promoters, we obtained common transcription regulation frameworks
(models). Taking into account the known involvement of speciﬁc
transcription factors in pancreas development, as well as degree of
conservation, we narrowed down signiﬁcantly the number of candidate
models. In these models, conserved in many species, NGN1/3 TFBS is co-
localized with other TFBSs for PDX1, HNF6, HNF1, and BRNF. The PDX1
family is representedby the factors PDX1and ISL1,which regulate islet cell
development and insulin gene expression [30–34]. The HNF6 and HNF1
families represented by the respective factors are both transcriptional
activators of pancreas-speciﬁc genes [30–34]. The identiﬁed enhancer
sequences contain also predicted binding sites for members belonging to
theBRNF transcription factor family. Themembers of this familyare BRN2,
BRN3, BRN4, and BRN5, transcription factors participating in mammalian
embryogenesis by regulating diverse patterns of gene expression. More
speciﬁcally, BRN4 plays a crucial role in specifying glucagon cell identity
[35,36]. Canonical Wnt signaling mediated by the LEFF family of
transcription factors is necessary for the proper expansion of pancreas
epithelium in the late phases of organogenesis [37]. The presence of these
transcription factor binding sites in the identiﬁed enhancer suggests that
this elementplaysan important roleonWISP1andCTGFregulationduring
pancreas development. Different sets of transcription factors are predicted
to bind to this enhancer at different stages of pancreas development, thus
coordinating expression of WISP1 and CTGF with pancreas development
(Fig. 5). Regulatory output can vary signiﬁcantly among different stages,
and transcription factor occupancy in any given stage may inﬂuence
occupancy in the following stage. In this manner the enhancer would act
as a temporal integrator during pancreas development.
CTGF and WISP1 were found to be regulated by canonical WNT
signaling in other cellular contexts [19, 20]. Strikingly, the identiﬁed
enhancer regions also contain binding motifs for the transcription
factor LEF1, which belongs to the transcription factor family LEFF and
mediates canonical WNT signaling [20]. This raises the possibility that
this enhancer is a focal regulatory point in diverse tissues. Its regulatory
output would be determined in a combinatorial manner depending on
tissue-speciﬁc transcription factor availability. The possibility that the
same enhancer is involved in regulation of these genes during neural
development merits particular reference, as a closely Ngn3-related
homolog, Ngn1, plays a role in neural tissue development [38].
Strikingly, additional conserved transcription factor binding sites
were identiﬁed in all the enhancers examined. These belonged to the
APR4, HOXF, and OCT1 families, which are large TF families including
many different members. Even though their heterogeneity is large,
these families contain transcription factors with a putative, though not
determined yet, implication in pancreas differentiation processes.
Interestingly, despite the conservation of several TFBSs in the same
Fig. 3. (A) The WISP1 ortholog model consisting of three elements belonging to the PDX1, BRNF, and NEUR transcription factor families, as it was identiﬁed from FrameWorker for
chimp, chick, zebraﬁsh, fugu, and frog. (B) The same framework shown in (A) was also identiﬁed by FrameWorker at some CTGF orthologs.
305M. Kapasa et al. / Genomics 92 (2008) 301–308enhancer across a wide phylogenetic distance in two related but
distinct genes, their orientation and relative positioning within the
enhancer are variable. This suggests that the selection pressure during
evolution is primarily on the presence of certain TFBSs and not on their
relative order or orientation in the primary sequence.
In summary, this study suggests that judicious combinatorial use of
bioinformatics analysis and biological knowledge could provide novel
hypotheses concerning the regulatory mechanisms governing gene
expression that could guide further experimental analysis.
Data and methods
Microarray and RT-PCR analysis
ESCs genetically engineered to inducibly express Ngn3were directed
toward pancreatic endoderm, and at that point, Ngn3 expression was
induced as described [18]. Differentiated embryoid bodies were
harvested and processed for RNA extraction and RT-PCR. Total RNA
was isolated using the RNeasy kit (Qiagen) according to the manufac-
turer’s instructions and then digested with RQ1 DNase (Promega) to
remove genomic DNA. First-strand cDNA synthesis was performed with
Superscript II reverse transcriptase (Invitrogen) using random primers.
Ampliﬁcation of cDNAs was performed by PCR using 25–35 cycles with
denaturation at 94°C for 30 s, annealing at 52–62°C for 60 s, and
extension at 72°C for 60 s. For single-cell RT-PCR, theOneStepRT-PCRKit
(Qiagen) was used according to the manufacturer's instructions. Singlecellswere isolatedusing amicromanipulatorﬁttedwith amicrocapillary
and transferred in 20 μl of 1× PCR Buffer before freezing in dry ice. The
content of each tubewas split in two, and a cycle of reverse transcription
followed by 40 cycles of PCR ampliﬁcationwas performed using primers
for Ngn3 and Ctgf, or for Ngn3 and Wisp1.
Primers were designed to span introns using the MacVector
software, and conditions were optimized using 10.5 dpc mouse
embryo total RNA. The forward and reverse primers and temperature
used for speciﬁc PCRs are:
WISP1: GGAGCAACGGTATGAGAACTGC and
TGATGGTCTTGGACTTGTAGGGG at 58°C)
CTGF ACCCGAGTTACCAATGACAATACC and
TAATGGCAGGCACAGGTCTTGAT at 57°C)
β-actin: ATGGATGACGATATCGCTGCGC and
TCTGTCAGGTCCCGGCCA at 60°C
PCR products were analyzed by agarose gel electrophoresis to
quantitatively compare the mRNA levels of the Ngn3-induced and
non-induced cells. Where appropriate, the mRNA levels of β-actin
were used as a control.
In silico Analysis of WISP1 and CTGF genes
Ortholog identiﬁcation and phylogenetic analysis
WISP1 and CTGF orthologs were identiﬁed with the best Blast hit
method [39,40]. The protein queries used were WISP1 and CTGF from
Fig. 4. The putative enhancer region, conserved in all WISP1 and CTGF orthologs, is presented forWISP1 (blue line) and CTGF (white line) sequences. The distance from the TSS (white
arrow) is represented on the dashed ruler line in base pairs (top of the ﬁgure). Symbols used for each transcription factor family are indicated below the ruler. The width of each
identiﬁed enhancer is denoted by the vertical ﬁne, black lines.
306 M. Kapasa et al. / Genomics 92 (2008) 301–308Mus musculus (Accession Nos. ENSMUSP00000005255 and
ENSMUSP00000020171 in the ENSEMBL database (http://www.
ensembl.org/index.html) for WISP1 and CTGF, respectively). If ortho-logous peptides were not detected, the genomic regions of the
orthologous genes were identiﬁed through Tblastn, and the respective
peptides were constructed by homology modeling using Wise2
Fig. 5. Pancreas development and the predicted occupancy of the identiﬁed enhancer in the respective stages. The shaded box represents the identiﬁed enhancer, whereas the
symbols denote different transcription factors. Question marks denote possible additional factors.
307M. Kapasa et al. / Genomics 92 (2008) 301–308(http://www.ebi.ac.uk/Wise2/). In cases where reciprocal Blast gave
short peptides showing only partial sequence similarity, we attempted
to construct the full-length ortholgs. The procedure followed included
EST identiﬁcation through Tblastn, further contig construction, and
translation using the respective tools at the followingwebsites: http://
bioinfo.hku.hk/Pise/cap.html (contig assembly), http://au.expasy.org/
tools/dna.html (contig translation). Genomic information for synteny
analysis was extracted from the Ensembl database (http://www.
ensembl.org/index.html). Once the orthologous peptide sequences
were selected, the alignment was performed usingMuscle3.6 [41] and
visualized through Bioedit [42] (http://www.mbio.ncsu.edu/BioEdit/).
The phylogenetic trees were reconstructed with the Neighbor Joining
method [43,44] using Bioedit and Phylip package [45] andwere further
visualized using Treeview [46].
Functional domain identiﬁcation
PFAM (http://www.sanger.ac.uk/cgibin/Pfam/getblast?id=
205J65wHW75cGZ96V1) was used to detect the four conserved
domains of both WISP1 and CTGF orthologs. The domains wereFig. 6. Schematic representation of the analysis carried out to identify conextracted and aligned using ClustalW (http://www.ebi.ac.uk/Tools/
clustalw/index.html), and the consensus sequences were constructed
with the help of Weblogo [47] (http://weblogo.berkeley.edu/).
Regulatory region analysis
The genomic regions of both WISP1 and CTGF orthologs spanning
4000 bp upstream to 400 bp downstream of the TSS were extracted
from the Ensembl and NCBI databases for the species shown in Fig 4.
These regions were submitted to the MatInspector platform in
Genomatix Database (http://www.genomatix.de/), and the common
TFBSs for all the sequences were presented. The MatInspector results
were obtained using all matrices from Matrix Library 6.3, core
similarity 0.75, and optimized matrix similarity. Using FrameWorker
in the same platform (http://www.genomatix.de/), we constructed
frameworks (models) consisting of at least two transcription factor
elements conserved in as many as possible of the submitted WISP1
promoter sequences. The minimum distance between two neighbor-
ing elements was set to 5 bp and the maximum distance to 500 bp.
Taking into account the experimental data indicating that WIPS1 is aserved regulatory regions for WISP1 and CTGF (see text for details).
308 M. Kapasa et al. / Genomics 92 (2008) 301–308direct target of Ngn3, the models were constructed setting the NEUR
family (including NGN1/3 and NEUROD1) as a mandatory element.
The sequences submitted to FrameWorker were 3500 bp long and
extracted from regions containing at least one NGN1/3 binding motif.
Using ModelInspector from the same Genomatix platform, we
scanned all the orthologous regions of WISP1 (extending from
4000 bp upstream to 400 bp downstream of the TSS) to ﬁnd the
exact location and the putative repeats of a selected model, consisting
of three elements. Next, using FrameWorker we sought a model
containing at least one NGN1/3 binding site. We further selected these
“model regions” together with the ﬂanking areas for WISP1 and CTGF
orthologs and searched for additional TFs contained therein. Fig. 6 is a
ﬂowchart summarizing this in silico based analysis.
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